BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

988 related articles for article (PubMed ID: 26406772)

  • 1. Revisiting Project Re-Engineered Discharge (RED): The Impact of a Pharmacist Telephone Intervention on Hospital Readmission Rates.
    Sanchez GM; Douglass MA; Mancuso MA
    Pharmacotherapy; 2015 Sep; 35(9):805-12. PubMed ID: 26406772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pharmacist-led medication management in care transitions.
    Yang S
    BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community pharmacy transition of care services and rural hospital readmissions: A case study.
    Patton AP; Liu Y; Hartwig DM; May JR; Moon J; Stoner SC; Guthrie KD
    J Am Pharm Assoc (2003); 2017; 57(3S):S252-S258.e3. PubMed ID: 28412054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate.
    Arnold ME; Buys L; Fullas F
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S36-42. PubMed ID: 25991594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a pharmacist-facilitated hospital discharge program: a quasi-experimental study.
    Walker PC; Bernstein SJ; Jones JN; Piersma J; Kim HW; Regal RE; Kuhn L; Flanders SA
    Arch Intern Med; 2009 Nov; 169(21):2003-10. PubMed ID: 19933963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a pharmacy-driven inpatient discharge counseling service: impact on 30-day readmission rates.
    Still KL; Davis AK; Chilipko AA; Jenkosol A; Norwood DK
    Consult Pharm; 2013 Dec; 28(12):775-85. PubMed ID: 24322961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
    Kalista T; Lemay V; Cohen L
    J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implementation of systematic medication reconciliation and review as part of the Lund Integrated Medicines Management model--impact on all-cause emergency department revisits.
    Hellström LM; Höglund P; Bondesson A; Petersson G; Eriksson T
    J Clin Pharm Ther; 2012 Dec; 37(6):686-92. PubMed ID: 22924464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ensuring continuity of patient care across the healthcare interface: Telephone follow-up post-hospitalization.
    Odeh M; Scullin C; Fleming G; Scott MG; Horne R; McElnay JC
    Br J Clin Pharmacol; 2019 Mar; 85(3):616-625. PubMed ID: 30675742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pharmacist involvement in the transitional care of high-risk patients through medication reconciliation, medication education, and postdischarge call-backs (IPITCH Study).
    Phatak A; Prusi R; Ward B; Hansen LO; Williams MV; Vetter E; Chapman N; Postelnick M
    J Hosp Med; 2016 Jan; 11(1):39-44. PubMed ID: 26434752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial.
    Bell SP; Schnipper JL; Goggins K; Bian A; Shintani A; Roumie CL; Dalal AK; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Labonville SA; Johnson D; Neal EB; Kripalani S;
    J Gen Intern Med; 2016 May; 31(5):470-7. PubMed ID: 26883526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postdischarge pharmacist medication reconciliation: impact on readmission rates and financial savings.
    Kilcup M; Schultz D; Carlson J; Wilson B
    J Am Pharm Assoc (2003); 2013; 53(1):78-84. PubMed ID: 23636160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of pharmacist telephone calls after discharge on satisfaction of oncology patients: A randomized controlled study.
    Salmany SS; Ratrout L; Amireh A; Agha R; Nassar N; Mahmoud N; Rimawi D; Nazer L
    J Oncol Pharm Pract; 2018 Jul; 24(5):359-364. PubMed ID: 28509614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a pharmacist-driven intervention program on hospital readmissions.
    Shull MT; Braitman LE; Stites SD; DeLuca A; Hauser D
    Am J Health Syst Pharm; 2018 May; 75(9):e221-e230. PubMed ID: 29691265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle.
    Koehler BE; Richter KM; Youngblood L; Cohen BA; Prengler ID; Cheng D; Masica AL
    J Hosp Med; 2009 Apr; 4(4):211-8. PubMed ID: 19388074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a pharmacist-led multidisciplinary transitions-of-care pilot for patients at high risk of readmission.
    Jones CD; Anthony A; Klein MD; Shakowski C; Smith HK; Go A; Perica K; Patel H; Pell J; Pierce R
    J Am Pharm Assoc (2003); 2018; 58(5):554-560. PubMed ID: 30017370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of follow-up telephone calls to patients after hospitalization.
    Dudas V; Bookwalter T; Kerr KM; Pantilat SZ
    Am J Med; 2001 Dec; 111(9B):26S-30S. PubMed ID: 11790365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Pharmacist Medication Education and Post-discharge Follow-up in Reducing Readmissions in Patients With ST-Segment Elevation Myocardial Infarction (STEMI).
    Budiman T; Snodgrass K; Komatsu Chang A
    Ann Pharmacother; 2016 Feb; 50(2):118-24. PubMed ID: 26681443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a clinical pharmacy specialist-managed telephonic hospital discharge follow-up program in a patient-centered medical home.
    Anderson SL; Marrs JC; Vande Griend JP; Hanratty R
    Popul Health Manag; 2013 Aug; 16(4):235-41. PubMed ID: 23537153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation and Effect of a Pharmacist-to-Pharmacist Transitions of Care Initiative on Ambulatory Care Sensitive Conditions.
    McFarland MS; Thomas AM; Young E; Bryant C; Hughes JC; Hoffman J; Baker JW
    J Manag Care Spec Pharm; 2020 Apr; 26(4):513-519. PubMed ID: 32223605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.